BioSpace News Archive

Business

AbbVie, Anima Strike mRNA Deal Worth Up to $582M

Tuesday, AbbVie partnered with Anima Biotech to discover and develop mRNA modulators in a collaboration of up to $582 million. The partnership will focus on three oncology and immunology targets.

January 10, 2023
·
2 min read
·
Tristan Manalac
Deals

JPM Day 2: Highlights

Stay on top of what’s happening at JPM. BioSpace is covering all the key announcements all week.

January 10, 2023
·
6 min read
·
BioSpace Staff
Business

Amgen Boasts Lucrative Acquisitions, Drug Updates, Burgeoning Biosimilars at JPM

In a presentation led by Robert J. Bradway, Amgen chairman and chief executive officer, the company covered recent acquisitions, Repatha and Lumakras updates, biosimilars and its broader financial outlook.

January 10, 2023
·
2 min read
·
Lisa Munger
Business

Despite Slowdown in COVID, Pfizer Promises Growth

Pfizer forecasts stable growth in the coming years, driven by a strong product push to cushion its non-COVID business and exclusivity losses.

January 10, 2023
·
2 min read
·
Tristan Manalac
Merck Highlights Growth Strategy at J.P. Morgan

The drugmaker’s presentation highlights its strong revenue growth, dominant vaccine business and expanding oncology portfolio.

January 10, 2023
·
3 min read
·
Alex Keown
Sponsored: Complete Genomics Touts Sequencing Platform, Product Launches at Biotech Showcase

Complete Genomics showcased its innovative sequencing capacity at the Biotech Showcase 2023, one of the year’s most important investor conferences.

January 10, 2023
·
4 min read
·
Editorial Staff
Aeterna Zentaris to Present at the Virtual Investor 2023 Companies to Watch Event

Aeterna Zentaris Inc. today announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna Zentaris, will present at the Virtual Investor 2023 Companies to Watch Event on Thursday, January 19, 2023 at 3:00 PM ET.

January 10, 2023
·
1 min read
Ceapro to Present at the Virtual Investor 2023 Companies to Watch EventLive video webcast on Wednesday, January 18th at 3:00 PM ET

Ceapro Inc. today announced that Gilles Gagnon, M.Sc., MBA, President and Chief Executive Officer of Ceapro, will present at the Virtual Investor 2023 Companies to Watch Event on Wednesday, January 18, 2023 at 3:00 PM ET.

January 10, 2023
·
1 min read
SAB Biotherapeutics Successfully Concludes IND-Enabling GLP Toxicology Study for SAB-142, a Novel Immunotherapeutic for Type 1 Diabetes

SAB Biotherapeutics today announced the successful completion of an IND-enabling GLP-tox study for SAB-142, further progressing the therapeutic as a way to prevent and/or delay onset and progression of type 1 diabetes (T1D) and potentially other T-cell mediated autoimmune diseases.

January 10, 2023
·
5 min read
Business

Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance

Inari Medical, Inc. today announced preliminary unaudited fourth quarter and full year 2022 revenue and provided estimates for its 2023 guidance.

January 10, 2023
·
3 min read